Predicted meta-omics: A potential solution to multi-omics data scarcity in microbiome studies
Clinical Snapshot
PICO Framework
| P — Population | Microbiome datasets with paired meta-omics data from various studies |
| I — Intervention | Machine learning models (elastic net regression, random forests, neural networks) to predict meta-omics features |
| C — Comparator | Experimental meta-omics data (ground truth) |
| O — Outcomes | Prediction accuracy (correlations), feature prediction reliability, downstream classification performance for inflammatory bowel disease |
Bottom Line
This methodological study demonstrates that machine learning models can predict metabolomic and transcriptomic profiles from metagenomic data with reasonable accuracy (correlations 0.74-0.77), potentially reducing the cost and complexity of multi-omics microbiome studies. The approach showed clinical utility by maintaining performance in inflammatory bowel disease classification tasks. However, protein prediction remained challenging, and the study lacks crucial methodological details including validation strategies, statistical significance testing, and dataset characteristics. While promising for research applications, clinical implementation would require rigorous validation across diverse populations and standardised protocols. Australian researchers could benefit from this approach to maximise value from existing metagenomic datasets, though careful validation would be essential before clinical application.
Key Findings
P Value: Not reported
Effect Size: Correlations up to 0.77 for transcripts, 0.74 for metabolites
Primary Outcome: Prediction accuracy of meta-omics features from metagenomics data
Nnt Or Sensitivity: Comparable performance to experimental data for IBD classification
Confidence Interval: Not reported
Clinical Application
Requires computational expertise and access to paired training datasets Could reduce costs for Australian microbiome research initiatives, relevant to NHMRC-funded studies and hospital-based microbiome programs Researchers studying gut microbiome in inflammatory bowel disease, diabetes, and cancer
Abstract
Imbalances in the gut microbiome have been linked to conditions such as inflammatory bowel disease, diabetes, and cancer. While metagenomics and amplicon sequencing are commonly used to study the microbiome, they do not capture all layers of microbial functions. Other meta-omics data can provide more insights, but these are more costly and laborious to procure. The growing availability of paired meta-omics data offers an opportunity to develop machine learning models that can infer connections between metagenomics data and other forms of meta-omics data, enabling the prediction of these other forms of meta-omics data from metagenomics. We evaluated several machine learning models for predicting meta-omics features from various meta-omics inputs. Simpler architectures such as elastic net regression and random forests generated reliable predictions of transcript and metabolite abundances, with correlations of up to 0.77 and 0.74, respectively, but predicting protein profiles was more challenging. We also identified a core set of well-predicted features for each meta-omics output type, and showed that multi-output regression neural networks performed similarly when trained using fewer output features. Lastly, our experiments demonstrated that predicted features can be used for the downstream task of inflammatory bowel disease classification, with performance comparable to that of experimental data.
References
- 1.Cosma, B. M., Pillay, S., Calderón-Franco, D., & Abeel, T. (2026). Predicted meta-omics: A potential solution to multi-omics data scarcity in microbiome studies. PLoS One. https://doi.org/10.1371/journal.pone.0345919
Related Research
The American journal of pathology
An Integrated Machine Learning and Genomic Framework for Precise Detection of Gastric Cancer
3 Aug 2026
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Artificial Intelligence Tools for Gastrointestinal Research: A Practical Guide
2 Aug 2026
Current opinion in critical care
Smart feeding: the role of artificial intelligence and integrated nutrition platforms in the ICU
2 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service